Investing Strategies

March 29, 2018

Companies covered: General Mills, Inc. (NYSE:GIS), Unilever NV (NYSE:UN), Amazon.com, Inc. (NASDAQ:AMZN), Polaris Industries Inc. (NYSE:PII), WPT Industrial Real Estate Investment (TSE:WIR.U), Twilio Inc (NYSE:TWLO), Vonage Holdings Corp. (NYSE:VG), Mimecast Ltd. (NASDAQ:MIME), Microsoft Corporation (NASDAQ:MSFT), Proofpoint, Inc. (NASDAQ:PFPT), Cisco Systems, Inc. (NASDAQ:CSCO), Corecivic Inc (NYSE:CXW), MasTec, Inc. (NYSE:MTZ), United Parcel Service, Inc. (NYSE:UPS), FedEx Corporation (NYSE:FDX), Franklin Resources, Inc. (NYSE:BEN), Medtronic, Inc. (NYSE:MDT), Bank Of New York Mellon Corporation (The) (NYSE:BK), Visa Inc. (NYSE:V), International Business Machines Corporation (NYSE:IBM), General Electric Company (NYSE:GE), Wal-Mart Stores, Inc. (NYSE:WMT), Best Buy Co., Inc. (NYSE:BBY), Macy's Inc (NYSE:M), Coca-Cola Company (The) (NYSE:KO), Costco Wholesale Corporation (NASDAQ:COST), Chipotle Mexican Grill, Inc. (NYSE:CMG), McDonald's Corporation (NYSE:MCD), Facebook, Inc. (NASDAQ:FB)

Buy ($175)

Proprietary Genome Editing Platforms

March 16, 2018

Companies covered: Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Novartis AG (NYSE:NVS), Gilead Sciences, Inc. (NASDAQ:GILD), bluebird bio, Inc. (NASDAQ:BLUE), Cellectis S.A. (NASDAQ:CLLS), Monsanto Company (NYSE:MON), Illumina, Inc. (NASDAQ:ILMN), Foundation Medicine, Inc. (NASDAQ:FMI), CRISPR Therapeutics AG (NASDAQ:CRSP), uniQure N.V. (NASDAQ:QURE), Spark Therapeutics, Inc. (NASDAQ:ONCE), AveXis Inc (NASDAQ:AVXS), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Regenxbio Inc (NASDAQ:RGNX), Oxford BioMedica plc (LON:OXB), Editas Medicine (NASDAQ:EDIT), Intellia Therapeutics (NASDAQ:NTLA), GenSight Biologics SA (EPA:SIGHT), ToolGen (KONEX:199800), Lysogene SA (EPA:LYS), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Adaptimmune Therapeutics plc (NASDAQ:ADAP), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Intrexon Corporation (NYSE:XON), Pfizer, Inc. (NYSE:PFE), Celgene Corporation (NASDAQ:CELG), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), Rocket Pharmaceuticals (NASDAQ:RCKT), Audentes Therapeutics (NASDAQ:BOLD), Fibrocell Science Inc (NASDAQ:FCSC)

Buy ($175)

Investing Strategies

March 14, 2018

Companies covered: AbbVie Inc. (NYSE:ABBV), Wal-Mart Stores, Inc. (NYSE:WMT), Amazon.com, Inc. (NASDAQ:AMZN), United States Steel Corporation (NYSE:X), Xerox Corporation (NYSE:XRX), General Motors Company (NYSE:GM), Square Inc (NYSE:SQ), Apple Inc. (NASDAQ:AAPL), Paypal Holdings Inc (NASDAQ:PYPL), Visa Inc. (NYSE:V), Mastercard Incorporated (NYSE:MA), eBay Inc. (NASDAQ:EBAY), Facebook, Inc. (NASDAQ:FB), Electronic Arts Inc. (NASDAQ:EA), Alphabet Inc (NASDAQ:GOOG), Tencent Holdings Ltd. (OTCMKTS:TCEHY), Alibaba Group Holding Limited (NYSE:BABA)

Buy ($175)

Biotechnology and Pharmaceuticals

March 08, 2018

Companies covered: Spero Therapeutics, Inc. (NASDAQ:SPRO), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Pfizer, Inc. (NYSE:PFE), AbbVie Inc. (NYSE:ABBV), Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM), Cellectis S.A. (NASDAQ:CLLS), Celsion Corporation (NASDAQ:CLSN), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Amgen Inc. (NASDAQ:AMGN), Gilead Sciences, Inc. (NASDAQ:GILD), Summit Therapeutics PLC (NASDAQ:SMMT), Spark Therapeutics, Inc. (NASDAQ:ONCE), Sage Therapeutics, Inc. (NASDAQ:SAGE), Achaogen Inc (NASDAQ:AKAO), Nabriva Therapeutics plc (NASDAQ:NBRV), Race Oncology Ltd. (ASX:RAC), Soligenix, Inc. (NASDAQ:SNGX), TiGenix (NASDAQ:TIG), Merck & Company, Inc. (NYSE:MRK), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), CRISPR Therapeutics AG (NASDAQ:CRSP), RXI Pharmaceuticals Corporation (NASDAQ:RXII), Oncolytics Biotech, Inc. (USA) (OTCMKTS:ONCYF), Cardiome Pharma Corporation (NASDAQ:CRME), Checkpoint Therapeutics Inc (NASDAQ:CKPT), Resverlogix Corp. (OTCMKTS:RVXCF), Illumina, Inc. (NASDAQ:ILMN), Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Buy ($175)

Oil & Gas: Downstream & Midstream

February 16, 2018

Companies covered: Kinder Morgan, Inc. (NYSE:KMI), Targa Resources, Inc. (NYSE:TRGP), MPLX LP (NYSE:MPLX), Marathon Petroleum Corporation (NYSE:MPC), Enterprise Products Partners L.P. (NYSE:EPD), Williams Companies, Inc. (The) (NYSE:WMB), Antero Midstream GP LP (NYSE:AMGP), Energy Transfer Equity, L.P. (NYSE:ETE), ENERGY TRANSFER PARTNERS (NYSE:ETP), ONEOK, Inc. (NYSE:OKE), United Parcel Service, Inc. (NYSE:UPS), Magellan Midstream Partners L.P. (NYSE:MMP), EnLink Midstream Partners, LP (NYSE:ENLK), Noble Midstream Partners LP (NYSE:NBLX), Semgroup Corporation (NYSE:SEMG), Macquarie Infrastructure Company LLC (NYSE:MIC), Antero Midstream Partners LP (NYSE:AM), Noble Corporation (NYSE:NE), Hess Midstream Partners LP (NYSE:HESM), CrossAmerica Partners LP (NYSE:CAPL), Sprague Resources LP (NYSE:SRLP), Martin Midstream Partners L.P. (NASDAQ:MMLP), USA Compression Partners, LP (NYSE:USAC), Blackbird Energy, Inc. (CVE:BBI), NiSource, Inc (NYSE:NI), Tetra Technologies, Inc. (NYSE:TTI)

Buy ($175)

Latest News